Evidence map›Paper›PMID 41732682›Full record

ArticleJournal of public health research2026

Cancer awareness in Georgia: A cross-sectional study of knowledge gaps in symptoms, risk factors, and screening programs.

Ketevan Gachechiladze, Ivane Kiladze, Tina Beruchashvili, Kakhaber Jakeli, Ivane Kechakmadze, Nino Ganugrava

Abstract read
In one paragraph

Article in Journal of public health research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ketevan GachechiladzeSchool of Health Sciences and Public Health, University of Georgia, Tbilisi, Georgia.ORCID https://orcid.org/0009-0003-6733-3467
Ivane KiladzeSchool of Medicine, Ilia State University, Tbilisi, Georgia.ORCID https://orcid.org/0000-0003-1553-3670
Tina BeruchashviliSchool of Health Sciences and Public Health, University of Georgia, Tbilisi, Georgia.ORCID https://orcid.org/0009-0009-4320-0436
Kakhaber JakeliSchool of Health Sciences and Public Health, University of Georgia, Tbilisi, Georgia.ORCID https://orcid.org/0000-0001-7505-5653
Ivane KechakmadzeFaculty of Science and Art, Ilia State University, Tbilisi, Georgia.ORCID https://orcid.org/0009-0009-0505-6832
Nino GanugravaSchool of Health Sciences and Public Health, University of Georgia, Tbilisi, Georgia.ORCID https://orcid.org/0009-0003-5181-424X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess public awareness of cancer symptoms, risk factors, and available screening programs, and to examine their association with sociodemographic parameters in Georgian population. Methods: A cross-sectional study (2023-2024) surveyed 385 adults via random-digit dialing using the Georgian version of the Cancer Awareness Measure (CAM), which comprises 9 symptom and 11 risk factor items. No stratification or demographic weighting was applied. A pilot test ( Results: Among the 385 respondents, 57.7% demonstrated low-to-average awareness of cancer symptoms. Women exhibited significantly greater awareness than men (β = 0.19, Conclusions: Improving cancer awareness and facilitating earlier diagnosis will require scalable, equity-oriented educational initiatives that account for gender and socioeconomic disparities. Implementing such programs across schools, primary care settings, and mass media, alongside the expansion of cancer screening services, may substantially enhance timely detection and reduce inequities in cancer outcomes.

Indexed as

CAM (cancer awareness measure)cancer awarenesscancer risk factorscancer symptomsGeorgiascreening

Identifiers

PMID41732682
PMCPMC12924935

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.